Skip to main content

Ardelyx, Inc.

ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001437402

In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Ardelyx, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of ARDX: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders10089−11
Shares42.1M39.9M−2.19M (−5.2%)
Value$46.0M$42.4M−$3.60M (−7.8%)

New holders (14)

Institutions that held Ardelyx, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ARDX in Q1 2022
InstitutionSharesValue% of portfolio
Great Point Partners LLC4,761,905$5.09M1.23%
Franklin Resources Inc304,800$326.0K0.00%
Bridgeway Capital Management, LLC100,000$107.0K0.00%
Mirabella Financial Services LLP47,600$51.0K0.01%
HCR Wealth Advisors20,000$21.0K0.00%
Commonwealth Equity Services, LLC17,100$18.0K0.00%
Ameriprise Financial Inc14,980$17.0K0.00%
Amalgamated Financial Corp.14,766$16.0K0.00%
FMR LLC13,804$15.0K0.00%
Wolverine Trading, LLC12,645$14.0K0.00%
World Equity Group, Inc.11,600$12.4K0.00%
Integrated Wealth Concepts LLC10,000$11.0K0.00%
Aquatic Capital Management LLC4,200$4.00K0.01%
Capital Advisors, Ltd. LLC168$00.00%

Sold out (25)

Institutions that held Ardelyx, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.